BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30844021)

  • 21. Outcome of patients treated surgically for lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
    Givi B; Andersen PE; Diggs BS; Wax MK; Gross ND
    Head Neck; 2011 Jul; 33(7):999-1004. PubMed ID: 21284049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
    Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
    Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node ratio as a prognostic factor in metastatic cutaneous head and neck squamous cell carcinoma.
    Vasan K; Low TH; Gupta R; Ashford B; Asher R; Gao K; Ch'ng S; Palme CE; Clark JR
    Head Neck; 2018 May; 40(5):993-999. PubMed ID: 29360276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis.
    Thompson AK; Kelley BF; Prokop LJ; Murad MH; Baum CL
    JAMA Dermatol; 2016 Apr; 152(4):419-28. PubMed ID: 26762219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymph node ratio relationship to regional failure and distant metastases in oral cavity cancer.
    Hosni A; McMullen C; Huang SH; Xu W; Su J; Bayley A; Bratman SV; Cho J; Giuliani M; Kim J; Ringash J; Waldron J; Spreafico A; Weinreb I; de Almeida JR; Brown DH; Irish JC; O'Sullivan B; Goldstein DP; Hope A
    Radiother Oncol; 2017 Aug; 124(2):225-231. PubMed ID: 28838425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma.
    Daniels CP; Bressel M; Corry J; Cole A; Chua MS; Tiong A; Hirshoren N; Dixon B; McDowell L
    Pract Radiat Oncol; 2020; 10(1):29-35. PubMed ID: 31606546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Programmed Cell Death Ligand 1 Expression on Immune Cells and Survival in Patients With Nonmetastatic Head and Neck Cancer: A Systematic Review and Meta-analysis.
    Blažek T; Petráš M; Knybel L; Cvek J; Soumarová R
    JAMA Netw Open; 2023 Mar; 6(3):e236324. PubMed ID: 37000447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the Rate of Skip Metastasis to Neck Level IV in Patients With Clinically Node-Negative Neck Oral Cavity Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
    Warshavsky A; Rosen R; Nard-Carmel N; Abu-Ghanem S; Oestreicher-Kedem Y; Abergel A; Fliss DM; Horowitz G
    JAMA Otolaryngol Head Neck Surg; 2019 Jun; 145(6):542-548. PubMed ID: 31070693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppression Impact on Head and Neck Cutaneous Squamous Cell Carcinoma: A Systematic Review with Meta-analysis.
    Elghouche AN; Pflum ZE; Schmalbach CE
    Otolaryngol Head Neck Surg; 2019 Mar; 160(3):439-446. PubMed ID: 30348055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Total Parotidectomy for Metastatic Cutaneous Squamous Cell Carcinoma and Malignant Melanoma.
    Thom JJ; Moore EJ; Price DL; Kasperbauer JL; Starkman SJ; Olsen KD
    JAMA Otolaryngol Head Neck Surg; 2014 Jun; 140(6):548-54. PubMed ID: 24722863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): a better outcome with surgery and adjuvant radiotherapy.
    Veness MJ; Palme CE; Smith M; Cakir B; Morgan GJ; Kalnins I
    Laryngoscope; 2003 Oct; 113(10):1827-33. PubMed ID: 14520114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous squamous cell carcinoma metastatic to the axilla and groin: Outcomes and prognostic factors.
    Bucknell NW; Gyorki DE; Bressel M; Estall V; Webb A; Henderson M; Chua MS; Rischin D; Tiong A
    Australas J Dermatol; 2022 Feb; 63(1):43-52. PubMed ID: 34751431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benchmarking Survival Outcomes Following Surgical Management of pT3 and pT4 Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    Yung AE; Crouch G; Varey AHR; Lo S; Elliott MS; Lee J; Rawson R; Gupta R; Hong AM; Clark JR; Ch'ng S
    Ann Surg Oncol; 2022 Aug; 29(8):5124-5138. PubMed ID: 35419758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical factors affecting regionally metastatic cutaneous squamous cell carcinoma to the parotid gland.
    Rao VM; Feng AL; Deschler DG; Kaufman HL; Lin DT; Miller D; Richmon JD; Shalhout SZ; Varvares MA; Emerick KS
    Head Neck; 2023 May; 45(5):1080-1087. PubMed ID: 36891633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
    Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
    Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck.
    Amit M; Liu C; Gleber-Netto FO; Kini S; Tam S; Benov A; Aashiq M; El-Naggar AK; Moreno AC; Rosenthal DI; Glisson BS; Ferrarotto R; Wong MK; Migden MR; Baruch EN; Li G; Khanna A; Goepfert RP; Nagarajan P; Weber RS; Myers JN; Gross ND
    Cancer; 2021 Apr; 127(8):1238-1245. PubMed ID: 33320343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Node-positive cutaneous squamous cell carcinoma of the head and neck: Survival, high-risk features, and adjuvant chemoradiotherapy outcomes.
    Amoils M; Lee CS; Sunwoo J; Aasi SZ; Hara W; Kim J; Sirjani D; Colevas AD; Chang AL; Divi V
    Head Neck; 2017 May; 39(5):881-885. PubMed ID: 28252823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
    Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
    Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent primary and metastatic cutaneous head and neck squamous cell carcinoma: Analysis of prognostic factors.
    McLean T; Brunner M; Ebrahimi A; Gao K; Ch'ng S; Veness MJ; Clark JR
    Head Neck; 2013 Aug; 35(8):1144-8. PubMed ID: 22907905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic dissection of level V in primary mucosal SCC in the clinically N positive neck: A systematic review.
    McLean T; Kerr SJ; Giddings CEB
    Laryngoscope; 2017 Sep; 127(9):2074-2080. PubMed ID: 28411387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.